ADHF clinical trials at UCSF
1 research study open to eligible people
ADHF is a sudden worsening of heart failure. UCSF is exploring the use of a device called Aortix to help heart failure patients. This trial compares the device with standard diuretic treatment.
Diuretics Alone Vs. Aortix Endovascular Device for Acute Heart Failure
open to eligible people ages 21 years and up
Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.
San Francisco, California and other locations
Last updated: